Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a Patient With Intellectual Developmental Disorder, Autosomal Dominant 7

Por um escritor misterioso
Last updated 12 abril 2025
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Intellectual developmental disorder, autosomal dominant 7 (MRD7; OMIM 614104) is a rare disease characterized by microcephaly, intellectual disability, speech delay, feeding difficulties, and facial dysmorphisms. This disorder is caused by pathogenic/likely pathogenic variants of the DYRK1A gene, which encodes dual-specificity tyrosine-phosphorylation-regulated kinase 1A. Here, we report a case of MRD7 that was diagnosed using Face2Gene and whole-exome sequencing (WES). A 22-year-old man presented with microcephaly, intellectual disability, slender body, long slender fingers, and facial dysmorphisms. He was previously diagnosed with Cornelia de Lange syndrome (CdLS) at four years of age. However, his CdLS clinical diagnostic score was low at 22 years of age. The Face2Gene application introduced several candidate diseases including MRD7. Finally, by utilizing WES and Sanger sequencing analysis of cloned cDNA, we identified a novel heterozygous duplication variant (c.848dup, p.(Asn283LysfsTer6)) in the DYRK1A gene, which introduces a premature stop codon. This report provides more information about the phenotypic spectrum of a young adult patient with MRD7. Face2Gene helped us introduce candidate diseases of the patient. Registering further genetically confirmed cases with MRD7 will improve the accuracy of the diagnostic recommendations in Face2Gene. Moreover, WES is a powerful tool for diagnosing rare genetic diseases, such as MRD7.
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder. - Abstract - Europe PMC
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole exome and targeted gene sequencing to detect pathogenic recessive variants in early onset cerebellar ataxia - Shakya - 2019 - Clinical Genetics - Wiley Online Library
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole exome sequencing in dense families suggests genetic pleiotropy amongst Mendelian and complex neuropsychiatric syndromes
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders, Orphanet Journal of Rare Diseases
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility, Pediatric Rheumatology
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
PDF) Next Generation Sequencing in Autism Spectrum Disorder
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Pitfalls of whole exome sequencing in undefined clinical conditions with a suspected genetic etiology
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Frontiers Case report: A novel de novo deletion mutation of DYRK1A is associated with intellectual developmental disorder, autosomal dominant 7
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole exome sequencing revealed variants in four genes underlying X-linked intellectual disability in four Iranian families: novel deleterious variants and clinical features with the review of literature, BMC Medical Genomics
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Publications using Face2Gene - Face2Gene
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Frontiers Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole-exome sequencing identifies two novel ALMS1 mutations in Indian patients with Leber congenital amaurosis

© 2014-2025 trend-media.tv. All rights reserved.